Ray Moynihan presents an investigative exploration of how the pharmaceutical industry's marketing strategies have broadened the boundaries of illness and created new patients. Drawing on case studies and journalistic analysis, the book traces how lower diagnostic thresholds and aggressive promotion can raise personal drug costs and stress public health systems.

The narrative examines corporate tactics, the medicalization of normal life, and the policy implications for health care funding and clinical practice. Readers will find evidence-based reporting that connects marketing decisions to real-world health and economic consequences.

Topics covered

• Pharmaceutical marketing and disease definition
• Impact on healthcare systems and costs
• Case studies and policy implications

Published by Greystone Books (2005), 254 pages — essential reading for health professionals, policy makers, and anyone interested in health policy and ethics.

We ship at a flat rate of $9.99 per order. Orders $35 and up ship free of charge.